posted on 2020-04-29, 20:45authored byYue Ruan, Alexis Bellot, Zuzana Moysova, Garry D. Tan, Alistair Lumb, Jim Davies, Mihaela Van Der Schaar, Rustam Rea
<b><i>Objective </i></b>
<p>We analyzed data from
inpatients with diabetes admitted to a large university hospital to predict the
risk of hypoglycemia through the use of machine learning algorithms.<i></i></p>
<p><b><i>Research
Design and Methods </i></b></p>
<p>Four years of data was
extracted from a hospital electronic health record system. This included
laboratory and point-of-care blood glucose (BG) values to identify biochemical
and clinically significant hypoglycaemic episodes (BG <u><</u> 3.9 and <u><</u>
2.9mmol/L respectively). We used patient demographics, administered
medications, vital signs, laboratory results and procedures performed during
the hospital stays to inform the model. Two
iterations of the dataset included the doses of insulin administered and the
past history of inpatient hypoglycaemia.
Eighteen different prediction models were compared using the area under
curve of the receiver operating characteristics (AUC_ROC) through a ten-fold
cross validation.</p>
<p><b><i>Results</i></b> </p>
<p>We analyzed data obtained
from 17,658 inpatients with diabetes who underwent 32,758 admissions between
July 2014 and August 2018. The predictive factors from the logistic regression model
included people undergoing procedures, weight, type of diabetes, oxygen
saturation level, use of medications (insulin, sulfonylurea, metformin) and
albumin levels. The machine learning model with the best performance was the XGBoost model (AUC_ROC 0.96. This outperformed
the logistic regression model which had an AUC_ROC of 0.75 for the estimation of
the risk of clinically significant hypoglycaemia.<b><i></i></b></p>
<p><b><i>Conclusions</i></b></p>
<p>Advanced machine learning
models are superior to logistic regression models in predicting the risk of
hypoglycemia in inpatients with diabetes.
Trials of such models should be conducted in real time to evaluate their
utility to reduce inpatient hypoglycaemia.</p>
Funding
YR salary was funded by Novo Nordisk Postdoctoral Fellowship run in partnership with the University of Oxford. RR, JD, GT, AL are partly funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC).